Aveanna holder sells 919K shares at $8

Aveanna Healthcare Holdings' major shareholder J.H.

Rhea-AI Filing Summary

Aveanna Healthcare Holdings' major shareholder J.H. Whitney VII, L.P., an entity associated with J.H. Whitney Equity Partners VII, LLC, reported an open-market sale of 919,389 shares of common stock at $8.00 per share on June 24, 2026. After this sale, J.H. Whitney VII, L.P. held 12,531,158 Aveanna shares indirectly. Related entities PSA Iliad Holdings LLC and PSA Healthcare Investment Holdings LLC were shown with 1,426,034 and 15,523,810 indirectly held shares, respectively, while direct holdings for the reporting person were listed as zero. The reporting entities may be deemed to share voting and dispositive power over these positions but disclaim beneficial ownership except to the extent of their pecuniary interest.

Insider Trade Summary

Net Seller: 919,389 shares

Net Sell 4 txns

Insider J.H. Whitney Equity Partners VII, LLC

Role 10% Owner

Sold 919,389 shs ($7.36M)

Type	Security	Shares	Price	Value
Sale	Common Stock, $0.01 par value	919,389	$8.00	$7.36M
holding	Common Stock, $0.01 par value	--	--	--
holding	Common Stock, $0.01 par value	--	--	--
holding	Common Stock, $0.01 par value	--	--	--

Holdings After Transaction: Common Stock, $0.01 par value — 12,531,158 shares (Indirect, By J.H. Whitney VII, L.P.); Common Stock, $0.01 par value — 0 shares (Direct); Common Stock, $0.01 par value — 15,523,810 shares (Indirect, By PSA Healthcare Investment Holdings LLC); Common Stock, $0.01 par value — 1,426,034 shares (Indirect, By PSA Iliad Holdings LLC)

Footnotes (1)

1. F1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

Key Figures

Shares sold: 919,389 shares Sale price: $8.00 per share Holdings after sale (J.H. Whitney VII, L.P.): 12,531,158 shares +3 more

6 metrics

Shares sold 919,389 shares Open-market sale on June 24, 2026

Sale price $8.00 per share Common Stock, $0.01 par value

Holdings after sale (J.H. Whitney VII, L.P.) 12,531,158 shares Indirect ownership following transaction

Indirect holdings PSA Iliad 1,426,034 shares Held indirectly by PSA Iliad Holdings LLC

Indirect holdings PSA Healthcare 15,523,810 shares Held indirectly by PSA Healthcare Investment Holdings LLC

Direct holdings 0 shares Direct ownership for reporting person after transactions

Key Terms

open-market sale, ten percent owner, indirect ownership, voting and dispositive power, +1 more

5 terms

open-market sale financial

"Sale in open market or private transaction"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ten percent owner regulatory

"is_ten_percent_owner": 1"

indirect ownership financial

"ownership_type": "indirect""

voting and dispositive power financial

"may be deemed to share voting and dispositive power with respect to shares"

beneficial ownership regulatory

"disclaims beneficial ownership of such securities except to the extent of its pecuniary interest"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aveanna Healthcare (AVAH) report in this Form 4?

Aveanna Healthcare (AVAH) disclosed an open-market sale of 919,389 common shares at $8.00 per share by J.H. Whitney VII, L.P. on June 24, 2026, reported through J.H. Whitney Equity Partners VII, LLC as a ten percent owner with indirect holdings.

Who executed the Aveanna Healthcare (AVAH) share sale reported in this filing?

The sale was executed by J.H. Whitney VII, L.P., a stockholder entity associated with J.H. Whitney Equity Partners VII, LLC. The filing notes this entity as an indirect owner and indicates it may share voting and dispositive power over the Aveanna Healthcare (AVAH) shares held.

How many Aveanna Healthcare (AVAH) shares does J.H. Whitney VII, L.P. hold after the sale?

Following the 919,389-share sale, J.H. Whitney VII, L.P. is shown holding 12,531,158 Aveanna Healthcare (AVAH) common shares indirectly. This figure reflects the position after the reported transaction and is separate from other indirect holdings reported for affiliated PSA investment entities.

What other Aveanna Healthcare (AVAH) indirect holdings are disclosed for related entities?

The filing lists 1,426,034 Aveanna Healthcare (AVAH) shares held indirectly by PSA Iliad Holdings LLC and 15,523,810 shares held indirectly by PSA Healthcare Investment Holdings LLC. These entities are managed through related funds connected to J.H. Whitney Equity Partners VII, LLC, according to the footnote disclosure.

Does J.H. Whitney Equity Partners VII, LLC claim full beneficial ownership of Aveanna (AVAH) shares?

No. The filing states J.H. Whitney Equity Partners VII, LLC and a related fund may be deemed to share voting and dispositive power, but each disclaims beneficial ownership of Aveanna Healthcare (AVAH) securities except to the extent of its pecuniary interest, limiting the ownership claim.

Was the Aveanna Healthcare (AVAH) insider sale a buy or sell transaction?

The reported Aveanna Healthcare (AVAH) transaction is a sale. It is coded as an open-market or private sale of 919,389 common shares at $8.00 per share, reflecting a net-sell position in the transaction summary, with no corresponding purchase transactions reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 01:35 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

J.H. Whitney Equity Partners VII, LLC

(Last) (First) (Middle)

212 ELM STREET

(Street)

NEW CANAAN CONNECTICUT 06840

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value								0	D(1)
Common Stock, $0.01 par value	06/24/2026		S		919,389	D	$8	12,531,158	I	By J.H. Whitney VII, L.P.(1)
Common Stock, $0.01 par value								15,523,810	I	By PSA Healthcare Investment Holdings LLC(1)
Common Stock, $0.01 par value								1,426,034	I	By PSA Iliad Holdings LLC(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

	/s/ David Zatlukal, Attorney-in-Fact	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)